The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells-Reference-Cited by-同舟云学术

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells

Published:2017-02-24 Issue:23 Volume:8 Page:37061-37079
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Estupina Pauline¹²³⁴,Fontayne Alexandre⁵,Barret Jean-Marc⁶,Kersual Nathalie¹²³⁴,Dubreuil Olivier⁶,Le Blay Marion¹²³⁴,Pichard Alexandre¹²³⁴,Jarlier Marta⁴,Pugnière Martine¹²³⁴,Chauvin Maëva¹²³⁴,Chardès Thierry¹²³⁴,Pouget Jean-Pierre¹²³⁴,Deshayes Emmanuel⁴,Rossignol Alexis⁷,Abache Toufik⁵,de Romeuf Christophe⁵,Terrier Aurélie⁵,Verhaeghe Lucie⁵,Gaucher Christine⁵,Prost Jean-François⁶,Pèlegrin André¹²³⁴,Navarro-Teulon Isabelle¹²³⁴

Affiliation:

1. IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, F-34298, France

2. INSERM, U896, Montpellier, F-34298, France

3. Université Montpellier, Montpellier, F-34298, France

4. Institut Régional du Cancer de Montpellier, ICM, Montpellier, F-34298, France

5. LFB Biotechnologies, Loos, F-59120, France

6. GamaMabs Pharma, Toulouse cedex, F-31106, France

7. Clean Cells, Boufféré, F-85600, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing;Methods in Cell Biology;2024

2. Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy;Journal of Nuclear Medicine;2023-10-19

3. Cancer-associated mesothelial cells are regulated by the anti-Müllerian hormone axis;Cell Reports;2023-07

4. Folate-based radiotracers for nuclear imaging and radionuclide therapy;Coordination Chemistry Reviews;2022-11

5. Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide;Pharmaceutics;2021-06-29